{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:57:38Z","timestamp":1792137458533,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T00:00:00Z","timestamp":1424217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12020-015-0551-8","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T03:34:53Z","timestamp":1424144093000},"page":"146-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases"],"prefix":"10.1007","volume":"50","author":[{"given":"Michail","family":"Kaklamanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Pikazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,18]]},"reference":[{"key":"551_CR1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"KG Saag","year":"2008","unstructured":"K.G. Saag, G.G. Teng, N.M. Patkar, J. Anuntiyo, C. Finney, J.R. Curtis et al., American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 59, 762\u2013784 (2008)","journal-title":"Arthritis Rheum."},{"key":"551_CR2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/eje.1.02140","volume":"154","author":"D Fassi El","year":"2006","unstructured":"D. El Fassi, C.H. Nielsen, H.C. Hasselbalch, L. Hegedus et al., The rationale for B lymphocyte depletion in Graves\u2019 disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option. Eur. J. Endocrinol. 154, 623\u2013632 (2006)","journal-title":"Eur. J. Endocrinol."},{"key":"551_CR3","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1111\/j.1572-0241.2002.07093.x","volume":"97","author":"WJ Sandborn","year":"2002","unstructured":"W.J. Sandborn, S.B. Hanauer, Infliximab in the treatment of Crohn\u2019s disease: a user\u2019s guide for clinicians. Am. J. Gastroenterol. 97, 2962\u20132972 (2002)","journal-title":"Am. J. Gastroenterol."},{"key":"551_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","volume":"43","author":"MP Vanderpump","year":"1995","unstructured":"M.P. Vanderpump, W.M. Tunbridge, J.M. French, D. Appleton, D. Bates, F. Clark et al., The incidence of thyroid disorders in the community. A twenty year follow-up of the Whickham survey. Clin. Endocrinol. 43, 55\u201368 (1995)","journal-title":"Clin. Endocrinol."},{"key":"551_CR5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199107253250410","volume":"325","author":"RD Utiger","year":"1991","unstructured":"R.D. Utiger, The pathogenesis of autoimmune thyroid disease. N. Engl. J. Med. 325, 278\u2013279 (1991)","journal-title":"N. Engl. J. Med."},{"key":"551_CR6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.11460","volume":"49","author":"F D\u00b4Arbonneau","year":"2003","unstructured":"F. D\u00b4Arbonneau, S. Ansart, R. Le Berre, M. Dueymes, P. Youinou, Y.L. Pennec, Thyroid dysfunction in primary Sjogren\u2019s syndrome: a long-term follow-up study. Arthritis Rheum. 49, 804\u2013809 (2003)","journal-title":"Arthritis Rheum."},{"key":"551_CR7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ard.52.6.454","volume":"52","author":"JB Shiroky","year":"1993","unstructured":"J.B. Shiroky, M. Cohen, M.L. Ballachey, C. Neville, Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann. Rheum. Dis. 52, 454\u2013456 (1993)","journal-title":"Ann. Rheum. Dis."},{"key":"551_CR8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","volume":"18","author":"JR Garber","year":"2012","unstructured":"J.R. Garber, R.H. Cobin, H. Gharib, J.V. Hennessey, I. Klein, J.I. Mechanick et al., Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr. Pract. 18, 988\u20131028 (2012)","journal-title":"Endocr. Pract."},{"key":"551_CR9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/acta.0.1210129","volume":"121","author":"R Gutekunst","year":"1989","unstructured":"R. Gutekunst, W. Hafermann, T. Mansky, P.C. Scriba, Ultrasonography related to clinical and laboratory findings in lymphocytic thyroiditis. Acta Endocrinol. 121, 129\u2013135 (1989)","journal-title":"Acta Endocrinol."},{"key":"551_CR10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/105072502760258712","volume":"12","author":"W Raber","year":"2002","unstructured":"W. Raber, A. Gessl, P. Nowotny, H. Vierhapper, Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects. Thyroid 12, 725\u2013731 (2002)","journal-title":"Thyroid"},{"key":"551_CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/thy.2000.10.251","volume":"10","author":"OM Pedersen","year":"2000","unstructured":"O.M. Pedersen, N.P. Aardal, T.B. Larssen, J.E. Varhaug, O. Myking, H. Vik-Mo, The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 10, 251\u2013259 (2000)","journal-title":"Thyroid"},{"key":"551_CR12","first-page":"185","volume":"94","author":"I Banaka","year":"2011","unstructured":"I. Banaka, G. Kaltsas, S. Antoniou, G. Kanakis, A. Zilos, C. Baltas et al., Prognostic value of vascularity index for the diagnosis of autoimmune thyroid disease. JBR-BTR 94, 185\u2013190 (2011)","journal-title":"JBR-BTR"},{"key":"551_CR13","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.7863\/ultra.32.11.1969","volume":"32","author":"I Banaka","year":"2013","unstructured":"I. Banaka, D. Thomas, G. Kaltsas, Value of the left inferior thyroid artery peak systolic velocity in diagnosing autoimmune thyroid disease. J. Ultrasound Med. 32, 1969\u20131978 (2013)","journal-title":"J. Ultrasound Med."},{"key":"551_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","volume":"43","author":"JC Mandac","year":"2006","unstructured":"J.C. Mandac, S. Chaudhry, K.E. Sherman, Y. Tomer, The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 43, 661\u2013672 (2006)","journal-title":"Hepatology"},{"key":"551_CR15","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(99)02429-0","volume":"354","author":"AJ Coles","year":"1995","unstructured":"A.J. Coles, M. Wing, S. Smith, F. Coraddu, S. Greer, C. Taylor, Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354, 1691\u20131695 (1995)","journal-title":"Lancet"},{"key":"551_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3899\/jrheum.100488","volume":"38","author":"HG Raterman","year":"2011","unstructured":"H.G. Raterman, A. Jamnitski, W.F. Lems, A.E. Voskuyl, B.A. Dijkmans, W.H. Bos, Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6\u00a0months of adalimumab treatment: a pilot study. J. Rheumatol. 38, 247\u2013251 (2011)","journal-title":"J. Rheumatol."},{"key":"551_CR17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","volume":"64","author":"C Eriksson","year":"2005","unstructured":"C. Eriksson, S. Engstrand, K.G. Sundqvist, S. Rantapaa-Dahlqvist, Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF\u03b1. Ann. Rheum. Dis. 64, 403\u2013407 (2005)","journal-title":"Ann. Rheum. Dis."},{"key":"551_CR18","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1089\/thy.2012.0489","volume":"23","author":"M Kaklamanos","year":"2013","unstructured":"M. Kaklamanos, D. Thomas, D. Pikazis, S. Christaki, G. Kaltsas, The effect of rituximab in thyroid function and autoimmunity. Thyroid 23, 1044\u20131045 (2013)","journal-title":"Thyroid"},{"key":"551_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315\u2013324 (1988)","journal-title":"Arthritis Rheum."},{"key":"551_CR20","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"E.M. Tan, A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield et al., The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25, 1271\u20131277 (1982)","journal-title":"Arthritis Rheum."},{"key":"551_CR21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"C. Vitali, S. Bombardieri, R. Jonsson, H.M. Moutsopoulos, E.L. Alexander, S.E. Carsons et al., European Study Group on Classification Criteria for Sjogren\u2019s Syndrome: classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554\u2013558 (2002)","journal-title":"Ann. Rheum. Dis."},{"key":"551_CR22","first-page":"3257","volume":"81","author":"Y Murakami","year":"1996","unstructured":"Y. Murakami, J. Takamatsu, S. Sakane, K. Kuma, N. Ohsawa, Changes in thyroid volume in response to radioactive iodine for Graves\u2019 hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. J. Clin. Endocrinol. Metab. 81, 3257\u20133260 (1996)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"551_CR23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1210\/edrv-3-2-164","volume":"3","author":"L Wartofsky","year":"1982","unstructured":"L. Wartofsky, K.D. Burman, Alterations in thyroid function in patients with systemic illness: the\u00a0\u00ab\u00a0Euthyroid Sick Syndrome\u00bb. Endocr. Rev. 3, 164\u2013217 (1982)","journal-title":"Endocr. Rev."},{"key":"551_CR24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1172\/JCI106283","volume":"49","author":"J Levy","year":"1970","unstructured":"J. Levy, E.V. Barnett, N.S. MacDonald, J.R. Klinenberg, Altered immunoglobulin metabolism in systemic lupus erythematosus and rheumatoid arthritis. J. Clin. Invest. 49, 708\u2013715 (1970)","journal-title":"J. Clin. Invest."},{"key":"551_CR25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2249.2008.03756.x","volume":"154","author":"LD Xie","year":"2008","unstructured":"L.D. Xie, Y. Gao, M.R. Li, G.Z. Lu, X.H. Guo, Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashomoto\u2019s thyroiditis with different thyroid functional status. Clin. Exp. Immunol. 154, 172\u2013176 (2008)","journal-title":"Clin. Exp. Immunol."},{"key":"551_CR26","first-page":"80","volume":"63","author":"R Jansson","year":"1986","unstructured":"R. Jansson, P. Thompson, F. Clark, S. McLachlan, Association between thyroid microsomal antibodies of subclass IgG-1 and hypothyroidism in autoimmune postpartum thyroiditis. Clin. Exp. Immunol. 63, 80\u201386 (1986)","journal-title":"Clin. Exp. Immunol."},{"key":"551_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.1.02325","volume":"156","author":"M Salvi","year":"2007","unstructured":"M. Salvi, G. Vannucchi, I. Campi, N. Curr\u00f2, D. Dazzi, S. Simonetta, Treatment of Grave\u2019s disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur. J. Endocrinol. 156, 33\u201340 (2007)","journal-title":"Eur. J. Endocrinol."},{"key":"551_CR28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1210\/jc.2006-2388","volume":"92","author":"D Fassi El","year":"2007","unstructured":"D. El Fassi, C. Nielsen, S. Bonnema, H. Hasselbalch, L. Hegedus, B lymphocyte depletion with the monoclonal antibody Rituximab in Grave\u2019s disease: a controlled pilot study. J. Clin. Endocrinol. Metab. 92, 1769\u20131772 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"551_CR29","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.170.7.3522","volume":"170","author":"Y Nagayama","year":"2003","unstructured":"Y. Nagayama, H. Mizuguchi, T. Hayakawa, M. Niwa, S.M. McLachlan, B. Rapoport et al., Prevention of autoantibody-mediated Graves\u2019-like hyperthyroidism in mice with IL-4, a Th2 cytokine. J. Immunol. 170, 3522\u20133527 (2003)","journal-title":"J. Immunol."},{"key":"551_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1480001","volume":"148","author":"AP Weetman","year":"2003","unstructured":"A.P. Weetman, Autoimmune thyroid disease: propagation and progression. Eur. J. Endocrinol. 148, 1\u20139 (2003)","journal-title":"Eur. J. Endocrinol."},{"key":"551_CR31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3899\/jrheum.090941","volume":"37","author":"D Kurosaka","year":"2010","unstructured":"D. Kurosaka, K. Hirai, M. Nishioka, Y. Miyamoto, K. Yoshida, K. Noda et al., Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J. Rheumatol. 37, 1121\u20131128 (2010)","journal-title":"J. Rheumatol."},{"key":"551_CR32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/ar575","volume":"4","author":"EM Paleolog","year":"2002","unstructured":"E.M. Paleolog, Angiogenesis in rheumatoid arthritis. Arthritis Res. 4, 81\u201390 (2002)","journal-title":"Arthritis Res."},{"key":"551_CR33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI118164","volume":"96","author":"K Sato","year":"1995","unstructured":"K. Sato, K. Yamazaki, K. Shizume, Y. Kanaji, T. Obara, K. Ohsumi et al., Stimulation by thyroid-stimulating hormone and Grave\u2019s immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J. Clin. Invest. 96, 1295\u20131302 (1995)","journal-title":"J. Clin. Invest."},{"key":"551_CR34","first-page":"3908","volume":"83","author":"M Iitaka","year":"1998","unstructured":"M. Iitaka, S. Miura, K. Yamanaka, S. Kawasaki, S. Kitahama, Y. Kawakami et al., Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Grave\u2019s disease and Hashimotos\u2019 thyroiditis. J. Clin. Endocrinol. Metab. 83, 3908\u20133912 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"551_CR35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/cncr.23251","volume":"112","author":"A Hauschild","year":"2008","unstructured":"A. Hauschild, H. Gogas, A. Tarhini, M.R. Middleton, A. Testori, B. Dreno et al., Practical guidelines for the management of interferon-\u03b1-2b side effects in patients receiving adjuvant treatment for melanoma. Cancer 112, 982\u2013994 (2008)","journal-title":"Cancer"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0551-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-015-0551-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-015-0551-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T23:58:45Z","timestamp":1566345525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-015-0551-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1007\/s12020-015-0551-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,18]]}}}